Goldman Sachs
GNVC

Goldman Sachs’s GenVec, Inc. GNVC Stock Holding History

Goldman Sachs’s Portfolio GNVC Stock Details GNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,435
Closed -$16K – 7391
2016
Q3 		$16K Sell
3,435
-105
-3% -$606 ﹤0.01% 6813
2016
Q2 		$20K Sell
3,540
-15
-0.4% -$105 ﹤0.01% 6730
2016
Q1 		$29K Buy
3,555
+542
+18% +$3.63K ﹤0.01% 6631
2015
Q4 		$55K Buy
3,013
+317
+12% +$6.06K ﹤0.01% 6492
2015
Q3 		$62K Sell
2,696
-581
-18% -$13.9K ﹤0.01% 6712
2015
Q2 		$67K Buy
3,277
+237
+8% +$5.78K ﹤0.01% 6782
2015
Q1 		$90K Sell
3,040
-564
-16% -$18.5K ﹤0.01% 6468
2014
Q4 		$75K Sell
3,604
-1,740
-33% -$33.6K ﹤0.01% 6687
2014
Q3 		$111K Buy
+5,344
New +$117K ﹤0.01% 6534

Other funds holding GNVC

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Goldman Sachs's GNVC Position: Q4 2016 in Review

Goldman Sachs sold out of GenVec, Inc. (GNVC) in Q4 2016, closing a stake of 3,435 shares — an estimated $16K sold.

Goldman Sachs first reported a position in GNVC in Q3 2014 and held it in 9 quarters. The position peaked at $111K in Q3 2014. 20 funds tracked by Wall St. Rank hold GNVC as of Q4 2016.

  • Goldman Sachs reported no remaining GenVec, Inc. position as of Q4 2016 after selling out during the quarter.
  • Goldman Sachs sold 3,435 GenVec, Inc. shares in Q4 2016, an estimated $16K.
  • Goldman Sachs first reported a position in GenVec, Inc. in Q3 2014 and held it in 9 quarters.
  • Goldman Sachs's GenVec, Inc. position peaked at $111K in Q3 2014.
  • 20 funds tracked by Wall St. Rank held GenVec, Inc. as of Q4 2016.

Based on Goldman Sachs's 13F filing for Q4 2016, filed 14 Feb 2017.